Ryman Healthcare posts strong FY26 cash rebound, shares hold firm
Ryman Healthcare reported fiscal 2026 results showing a 10% rise in operating revenue to NZ$849 million, a 94% increase in EBITDAF to NZ$88 million, and free cash flow of NZ$188 million. The company said its two-year operational reset has driven improved profitability and cash generation. Macquarie reaffirmed an Outperform rating and highlighted a …